Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies

NCT02369458 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck
Squamous Cell Carcinoma, Head and Neck

Interventions

DRUG: Mitomycin-C
DRUG: Pegfilgrastim

Sponsor

Washington University School of Medicine